Mounjaro (tirzepatide) is an injectable prescription medication used to treat type 2 diabetes in adults. It helps lower blood sugar levels, along with diet and exercise, by increasing insulin production, preventing the liver from releasing stored sugar, and slowing the absorption of food and drinks.¹

Key Benefits:

- Improved Blood Sugar Control: Mounjaro has been shown to lower A1C levels, with 75% to 90% of patients reaching an A1C of less than 7%.

- Weight Loss: Patients taking Mounjaro have reported weight loss, ranging from 12 pounds (5 mg) to 25 pounds (15 mg).

- Convenient Administration: Mounjaro is administered via a single-dose pen, which is easy to use and requires no mixing.²

Important Safety Information:

- Thyroid Cancer Risk: Mounjaro may increase the risk of thyroid cancer, and patients with a history of thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not use it.³

- Pancreatitis Risk: Mounjaro may increase the risk of pancreatitis, and patients with a history of pancreatitis should use caution.

- Hypoglycemia Risk: Mounjaro may increase the risk of low blood sugar when used with insulin or other diabetes medications.